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Abstract
Neonatal interstitial lung diseases due to abnormal surfactant biogenesis are rare in humans
and have never been reported as a spontaneous disorder in animals. We describe here a
novel lung disorder in Airedale Terrier (AT) dogs with clinical symptoms and pathology simi-
lar to the most severe neonatal forms of human surfactant deficiency. Lethal hypoxic respi-
ratory distress and failure occurred within the first days or weeks of life in the affected
puppies. Transmission electron microscopy of the affected lungs revealed maturation arrest
in the formation of lamellar bodies (LBs) in the alveolar epithelial type II (AECII) cells. The
secretory organelles were small and contained fewer lamellae, often in combination with
small vesicles surrounded by an occasionally disrupted common limiting membrane. A com-
bined approach of genome-wide association study and whole exome sequencing identified
a recessive variant, c.1159G>A, p.(E387K), in LAMP3, a limiting membrane protein of the
cytoplasmic surfactant organelles in AECII cells. The substitution resides in the LAMP
domain adjacent to a conserved disulfide bond. In summary, this study describes a novel
interstitial lung disease in dogs, identifies a new candidate gene for human surfactant dys-
function and brings important insights into the essential role of LAMP3 in the process of the
LB formation.
Author summary
We have characterized a lethal lung disease in neonatal Airedale Terrier dogs. The patho-
logical features of the disease resemble those of the surfactant dysfunction in newborn
babies. Surfactant is essential for lung function and we observed a maturation defect in
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the surfactant producing organelles of the lung epithelial type II cells. Genetic analyses
revealed a recessive variant in the lysosome associated membrane LAMP3 gene. LAMP3 is
a structural, limiting membrane protein of the surfactant organelles. This study provides
an excellent candidate gene for human surfactant disorders as well as new insights into
LAMP3 biology and pathophysiology while the affected breed will benefit from genetic
testing to eradicate this severe disease.
Introduction
Pulmonary surfactant is a mixture of lipids and proteins essential for life that form a thin sur-
face lining film in the gas exchange compartment of the lungs, the alveolus. Surfactant reduces
the surface tension at the interface of air and liquid, preventing the alveoli from collapsing at
the end of expiration. Surfactant is composed of lipids (~ 90%) with a small fraction (~10%) of
mainly four surfactant proteins (SPs), SP-A, SP-B, SP-C and SP-D. The synthesis and assembly
of surfactant occurs via distinct pathways within the AECII cells [1]. This processing requires
developmental stages of special cytoplasmic organelles: first, multivesicular bodies (MVBs);
second, composite bodies (CBs) and finally, mature LBs [2]. LBs store and secrete the pro-
duced surfactant into alveolar space by exocytosis [3]. AECII cell LBs are lysosome-related
organelles that have common features with lysosomes, such as biogenesis, low internal pH and
similarities in membrane components, yet they are cell-specific in morphology, function and
composition [4,5].
Even a small defect that affects the complex pathway of LB formation or surfactant metabo-
lism can have fatal consequences. Genetic dysfunctions of surfactant biogenesis that present in
newborn infants constitute a subgroup of rare, diffuse childhood interstitial lung diseases that
manifest as hypoxic respiratory distress or failure [6]. Three genes have been associated with
primary congenital surfactant dysfunction in newborn babies: ATP-binding cassette, subfam-
ily A, member 3, ABCA3 (OMIM �601615, #610921); surfactant, pulmonary-associated protein
B, SFTPB (OMIM �178640, #265120); and surfactant, pulmonary-associated protein C, SFTPC
(OMIM �178620, #610913). The characteristic light microscopical changes include varying
amount of proteinaceous material and macrophages in air spaces, AECII cell hyperplasia,
arrested acinar development, lower number of alveoli and diffuse parenchymal changes of
interstitial thickening with mesenchymal cells [7–9]. Overlapping morphological diagnoses
can be made depending on the gene, duration of the condition and time point of biopsy [6].
Dogs have become excellent natural models for human disease as inherited disorders have
been enriched in many dog breeds due to strict selective breeding schemes and breed struc-
tures [10,11]. With the rapid advancement of gene technologies, studies in dogs have unrav-
eled novel disease genes and mechanisms [12–16]. These discoveries can advance the
understanding of the corresponding human diseases, while animals and breeding programs
will benefit from genetic testing.
Surfactant dysfunctions have not been previously reported as a spontaneous disease in neo-
natal animals. We describe here the first such example by identifying the genetic cause of a
lethal diffuse interstitial lung disease in AT dogs with a novel missense variant in lysosome
associated membrane 3, LAMP3. LAMP3 (also known as DC-LAMP, CD208) [17,18] localizes
at the limiting membrane of surfactant organelles in AECII cells [19] and we demonstrate here
how its defect arrests the maturation of LBs, resulting in a lethal deficiency of pulmonary sur-
factant in the affected AT puppies.
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Results
Respiratory symptoms and lung-specific pathology in the affected puppies
All 25 affected puppies were born at term with normal delivery. One was stillborn. Six (24%)
were lethargic at birth, refused to suckle and developed dyspnea or tachypnea and died or
were humanely euthanized at 4–18 hours later. The rest of the puppies (72%) were initially
normal until the difficulties in breathing started. Most of these puppies died during one to
four days (64%), except one puppy that survived for 7 days and one up to 4 weeks.
Full necropsy was performed for the 25 puppies and the main lesion was in the lungs. The
lungs of all the puppies, except the 4-week-old, were edematous, congested and appeared
poorly aerated (Fig 1A). At four weeks the lungs had a rubbery texture and marked emphy-
sema (Fig 1B). No significant macroscopic changes were detected in other organs.
The lungs of the stillborn puppy were at the normal saccular stage of maturation [20]. Some
of the alveolar spaces contained strands and globules of Periodic acid Schiff (PAS) -positive
eosinophilic material and macrophages. There was no atelectasis. In the puppies that died
4–18 hours after birth, the alveolar septa were wider than normal and there was copious
amount of dense PAS-positive material in the airspaces and proximal bronchioles. There was
no atelectasis but numerous macrophages in the airspaces. In the one to four days age group,
Fig 1. Macroscopical changes and histology of the affected and control lungs. (A) The lungs of the 3-day-old affected puppy are diffusely
edematous and congested with only small visibly aerated area in the dorsal part of the right cranial lung lobe (black arrowheads). (B) In the affected
lung of the 3-day-old puppy, the alveoli are small and collapsed in many areas and the alveolar walls are wide. The airspaces contain abundant
eosinophilic material (black arrowheads) (Periodic acid Schiff (PAS) stain, 20X, scale bar 100 μm). (C) The morphology of the control lung
corresponds to the normal saccular stage of development of 3-day-old puppies (PAS stain, 20X, scale bar 100 μm). (D) In the 28-day-old affected
puppy, the lungs are rubbery in texture with multifocal emphysema (black arrowheads). (E) In the affected lung of the 28-day-old puppy, the
alveolar septa are wide and contain increased amount of collagenous connective tissue (blue) and there are numerous macrophages and
desquamated cells within the alveoli (Masson trichrome stain, 20X, scale bar 100 μm). (F) The morphology of the control lung of a 28-day-old
puppy is normal for the alveolar stage of lung development. The alveolar septa are thin with normal amount of collagenous connective tissue (blue)
(Masson trichrome stain, 20X, scale bar 100 μm).
https://doi.org/10.1371/journal.pgen.1008651.g001
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there was multifocal atelectasis and emphysema in addition to changes described previously
(Fig 1C and 1D). In the one- and four-week-old puppies, the emphysema was severe with
intervening areas of atelectasia. There were numerous desquamated cells and macrophages in
the alveoli and multifocal AECII cell hyperplasia. At four weeks, the lungs had a honeycomb
pattern with rounded alveoli surrounded by thick interstitium containing increased amount of
connective tissue indicating that the alveolar proteinosis had progressed to fibrosing interstitial
lung disease (Fig 1E and 1F).
Electron microscopy reveals a defect in the maturation and biogenesis of
LBs
For the characterization of ultrastructural changes in the lung, we performed transmission
electron microscopy (TEM) in one affected and one age-matched, unaffected control puppy.
In the control, the preservation and ultrastructural appearance of the alveolar epithelium was
excellent with AECII cells present as single cuboidal cells next to thin cell extensions of type I
alveolar epithelial cells (AECI) (Fig 2A). The characteristic surfactant-containing secretory
Fig 2. Transmission electron microscopy of the control and affected lungs. (A) Age-matched control. An intact AECII cell showing normal LBs with
tightly packed lamellae (arrowheads). In the alveolar airspace, surfactant is still in the form of multiple concentric lamellar whorls (arrows) (scale bar
2 μm). (B) Age-matched control. Multiple cytoplasmic LBs showing intact limiting membranes with intraorganellar, parallel packed phospholipid
lamellae (arrowheads) (scale bar 1 μm). (C) Affected puppy. AECII cell hyperplasia in the alveolar wall with three severely altered AECII cells (asterisks)
in apposition (scale bar 2 μm). (D) Affected puppy. A high power view of the cytoplasm of an AECII cell showing structures compatible with CBs (black
arrowheads) without any mature LBs. The limiting membrane is occasionally disrupted (white arrowheads) (scale bar 1 μm).
https://doi.org/10.1371/journal.pgen.1008651.g002
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organelles in AECII cells were mainly visible as mature LBs with tightly packed lamellae sur-
rounded by a limiting membrane (Fig 2B).
In the affected animal, the ultrastructure of AECII cells was severely altered. The AECII
cells appeared in clusters, which indicates cell hyperplasia. Their nuclear chromatin was mar-
ginalized, the perinuclear cisterna was dilated, the mitochondria were swollen, and the cyto-
plasmic matrix was less dense (i.e. less electron scattering) (Fig 2C). The secretory organelles
were smaller and contained fewer lamellae, often in combination with small vesicles sur-
rounded by an occasionally disrupted common limiting membrane (Fig 2D). These organelles
were immature and represented CBs, the intermediate step in LB biogenesis between MVBs
and mature LBs.
Genetic analyses identify a variant in LAMP3
As the pedigree of the affected puppies was suggestive of an autosomal recessive inheritance
for the disease (Fig 3), we combined genome-wide association study (GWAS) and a whole-
exome sequencing (WES) approaches to find the candidate causative variant. A GWAS with 5
affected and 24 unaffected AT dogs revealed 198 SNPs with genome-wide significance on
chromosome 34 between 12,013,938–22,402,691 bp (S1 Table). Fifteen most significant SNPs
(praw = 7.161 × 10−10, pBonferroni = 6.689 × 10−5) were located at 15,092,907–17,132,621. Assess-
ment of the genotypes revealed a 3.9 Mb homozygous region at 13,290,333–17,170,957 in the
affected puppies (Fig 4A–4D). The analysis of WES data from two affected and one obligate
carrier yielded 347 case-specific homozygous variants, of which 22 were exonic. Only three
private coding variants in LAMP3, ABCC5 and KLHL6 resided in the associated region in the
Fig 3. A pedigree of the 25 affected puppies. The segregation of the LAMP3 variant in the pedigree indicates autosomal recessive inheritance. Black symbol denotes
homozygous mutant (A/A), half-filled denotes heterozygous carrier (G/A) and white symbol denotes wild type (G/G). The individuals with gray symbol were not
available for genotyping.
https://doi.org/10.1371/journal.pgen.1008651.g003
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affected puppies (Table 1) and were not observed in 197 unaffected dogs from 67 breeds and 3
wolves (S3 Table). LAMP3 is properly annotated in NCBI (release 105, Gene ID: 607186) but,
to our understanding, erroneously interpreted as MCF2L2-201 transcript (ENSCAFT00000
018703.3) in Ensembl (release 95) and UCSC. The genotyping of the three variants in 16
affected puppies and 15 close relatives revealed that all the affected dogs were homozygous for
Fig 4. Genetic analyses reveal a missense variant in LAMP3. (A) The results of a GWAS with 5 cases and 24 controls reveal an association in chromosome
34. The most significant markers achieve genome-wide significance (praw = 7.161×10−10, pBonf = 6.689×10−5). The genome-wide significance threshold at
5.5×10−7 is indicated in red. (B) A regional association plot of the locus in chromosome 34. (C) The associated 3.9 Mb region in chromosome 34 contains 57
genes as annotated by NCBI (release 105), including LAMP3, KLHL6 and ABCC5. (D) The genotype data shows a shared homozygous 3.9 Mb haplotype
block in the affected puppies. The location of the LAMP3 variant is denoted with an arrow, as the distances between markers in the genotype image do not
directly correspond to images C and D. (E) Chromatograms and the nucleotide and consequent amino acid change (p.(E387K)) of the LAMP3 missense
variant. The LAMP3 gene is coded on the reverse strand. The chromatograms are shown for homozygous mutant (A/A), heterozygous (G/A) and wild-type
(G/G) individuals.
https://doi.org/10.1371/journal.pgen.1008651.g004
Table 1. Case-specific coding variants found in whole exome sequencing data in the associated locus.
Gene Protein Genomic coordinates Coding sequence
variant
Amino acid consequence Predicted effect










KLHL6 kelch-like family member 6 chr34:16447091G>A c.1713C>T
XM_545220.6
p.(I571I) XP_545220.3 No effect
https://doi.org/10.1371/journal.pgen.1008651.t001
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the alternate alleles whereas unaffected obligate carriers were heterozygotes and controls wild
type, suggesting a strong linkage disequilibrium between the variants.
KLHL6 is involved in B-lymphocyte antigen receptor signaling and its variants have been
associated with B-cell lymphomas and chronic lymphocytic leukemias [21]. Given the gene’s
unlikely role in primary lung disease and that the identified KLHL6 c.1713C>T, p.(I571I) vari-
ant was synonymous, we focused further analyses on the nonsynonymous variants in LAMP3
and ABCC5. ABCC5 is ubiquitously expressed in tissues and acts as a general transporter of
glutamate conjugates [22] and Abcc5-/- mice have a normal cellular phenotype [23]. LAMP3 is
a lysosome-associated membrane protein that is co-expressed in the limiting membrane of
alveolar AECII cell LBs with ABCA3, whose defects can result in surfactant dysfunction (Fig
5A) [19,24]. Altogether, we genotyped the LAMP3 and ABCC5 variants in 371 affected and
control AT dogs and found that both variants fully segregated with the disease under recessive
model (25/371 homozygous mutant, 77/371 heterozygous carrier, 269/371 homozygous wild
type) (Fig 4E). In this cohort, the carrier frequency was 20.6%.
Whole genome sequencing
To further investigate the structural and non-coding variant content in the associated locus,
we performed whole genome sequencing in one affected dog. The WGS data from this dog
was filtered against 887 control genomes (S4 Table) and revealed only two private coding vari-
ants (Table 2, S5 Table). The two coding variants in LAMP3 and ABCC5 were the same as pre-
viously discovered by WES (Table 1). The WGS analysis revealed many case-specific intronic
or intergenic variants but they were excluded as candidates because they were not located in
highly conserved regions (S5 Table). Structural variant and mobile element analysis revealed
548 structural variants and 446 mobile elements in the associated region. Only one predicted
case-specific intergenic SINE was observed in the locus (chr34:14462208) but was not consid-
ered as a candidate for the disease as the variant was intergenic.
Fig 5. The LAMP3 variant in the affected puppies. (A) A schematic representation of a lung AECII cell. During surfactant production, ABCA3, SP-B, SP-C
and LAMP3 are delivered to the LBs via endoplasmic reticulum (ER), Golgi, MVBs and CBs whereas lipids pass Golgi on their path to LBs. (B) A simplified
topology diagram of the LAMP domain in the LAMP3 protein. The p.(E387K) variant (denoted by red arrow) resides next to a conserved cysteine residue
that participates in the formation of the second disulfide bond. (C) A schematic representation of all the domains in the LAMP3 protein.
https://doi.org/10.1371/journal.pgen.1008651.g005
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In silico evaluation of the pathogenicity of the candidate variants
The pathogenicity of the two candidate variants from WES and WGS analyses was assessed
with Provean and PredictSNP [25,26]. The ABCC5 p.(P842S) variant was predicted as neutral
(Provean score -0.005, cutoff -2.5 and PredictSNP 83% confidence) and the LAMP3 p.(E387K)
variant as deleterious (Provean score -3.430, cutoff -2.5 and PredictSNP 72% confidence). The
LAMP3 p.(E387K) amino acid change resides in the LAMP domain just adjacent to the fourth
conserved cysteine residue that participates in the second disulfide bond (Fig 5B and 5C). Fur-
thermore, the conservation of p.E387 was evaluated across 36 species with multiple alignment
generated with Clustal Omega [27]. The result suggests conservation of the residue (S6 Table).
Collectively, these results highlight LAMP3 and its predicted deleterious variant as a likely
cause of the recessive disease in the AT breed.
Screening of the LAMP3 variant
After the initial cohort of 371 AT dogs that were screened for the LAMP3 variant, owners had
submitted blood samples from 20 additional adult, non-affected AT dogs. As they were
screened, one of these dogs, a dam that had had a litter that included affected puppies, turned
out to be homozygous for the LAMP3 variant (Fig 3). At the time of sampling, the dam was 6
years of age and, according to its owner, had been clinically healthy all its life without any signs
of respiratory disease. To study the possible differences of the variants in the associated locus
between the dam and the affected puppy, the whole genome of the dam was also sequenced
and compared with the affected puppy. This analysis did not reveal any dam-specific heterozy-
gous variants, which would have indicated that our LAMP3 variant is not causal but instead in
LD with the true disease-causing variant. In contrast, this result suggests that the dam may
have an unknown protective variant. Recently, modifier variants that afford resilience to severe
disease-causing variants have been found, suggesting that incomplete penetrance in Mendelian
diseases is not as rare as previously thought [28–31]. Finally, to investigate the breed specificity
of the LAMP3 variant, we screened additional 6940 dogs from 297 breeds, including eight
Airedale Terriers (S7 Table). Only one heterozygous dog, an Airedale Terrier, was identified,
which indicates that the LAMP3 variant is specific to the breed.
Immunohistochemistry of LAMP3, SP-B and SP-C in the lung
It is possible that the LAMP3 p.(E387K) amino acid substitution may distort the native confor-
mation of the protein or affect the expression, intracellular processing or localization of
LAMP3. Furthermore, as a limiting membrane protein, it may also have an effect on the pro-
cessing of surfactant proteins. To evaluate the effect of the variant, we assessed the expression
of LAMP3, SP-B and SP-C by immunohistochemistry. In the affected and control puppies,
there were similar LAMP3 positive cytoplasmic granular to small globular and ring like struc-
tures in the cytoplasm of the alveolar epithelial cells (designated as AECII cells). Moreover,
there was no difference in the intensity of staining between the groups (Fig 6A and 6B). In the
Table 2. Variants identified in the whole genome of the affected dog.
total number of variants 6740456
variants in the locus region
(chr34: 13,290,333–17,170,957)
79066
of which homozygous 78811
of which private 24
of which exonic 2
https://doi.org/10.1371/journal.pgen.1008651.t002
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one- and four-week-old puppies, there was slightly higher number of positive cells and many
positively stained desquamated intra-alveolar cells and possibly macrophages indicating
phagocytosis of the desquamated AECII cells. Hence, the mutant LAMP3 protein is equally
expressed and localized in the alveolar AECII cells compared to native LAMP3.
The stillborn puppy had occasional SP-B positive strands in the alveolar spaces in addition
to normal positive staining of a few alveolar lining cells (designated as AECII) and numerous
bronchiolar epithelial cells. In the affected dogs, the bronchiolar staining decreased and alveo-
lar staining increased with age and in the one- and four-week-old puppies the number of posi-
tive alveolar epithelial cells was significantly higher in the affected puppies compared to age-
matched controls indicating AECII hyperplasia. The alveolar PAS positive material stained
intensely positive with SP-B (Fig 6C and 6D). In the one- and four-week-old puppies, there
was also positive staining of the desquamated cells within the alveoli.
With the polyclonal SP-C antibody, there was positive cytoplasmic staining of the alveolar
epithelial cells (designated as AECII). In the affected puppies, the number of positive cells
increased with age and in the one- and four-week old puppies the number was significantly
higher in the affected puppies compared to age-matched controls, indicating hyperplasia (Fig
6E and 6F).
Discussion
This study provides new insights to the biology of surfactant dysfunctions with a novel disease
gene, LAMP3. First, we describe a spontaneous interstitial lung disease in dogs with clinical
symptoms and pathology corresponding to the most severe congenital forms of human
Fig 6. LAMP3, SP-B and SP-C immunohistochemistry. In the affected (A) and age matched 3-day-old control puppies (B), LAMP3 protein
expression was detected as granular, globular to ring-like intracytoplasmic structures (red) in the AECII cells (100X, Z-stack, scale bar 20 μm). In
the affected 3-day-old puppy (C), the proteinaceous material in the airspaces stained intensely with SP-B antibody (red), whereas in the age-
matched control (D), SP-B positive staining was detected only in the cytoplasm of AECII cells and the epithelium of few bronchioles (10X, scale bar
200 μm). In the 28-day-old affected puppy (E), the significant increase of the SP-C positive cells (red) indicated AECII hyperplasia. In comparison,
the age-matched control (F) had only scattered SP-C positive AECII cells in the alveolar epithelium (10X, scale bar 200 μm).
https://doi.org/10.1371/journal.pgen.1008651.g006
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surfactant dysfunctions associated with abnormal LB formation in the alveolar AECII cells.
Second, we found that LBs were underdeveloped and in the developmental stage of CBs in the
affected AECII cells, which demonstrates an impairment in the formation of mature LBs. Fur-
thermore, the common limiting membrane of CBs was occasionally disrupted, suggesting a
defect in the formation of the limiting membrane. Finally, we identify a variant in LAMP3,
which is a highly relevant candidate gene in these disorders.
The pathology of the affected puppies corresponds to the severe disorders of surfactant bio-
genesis in human infants. The typical histological changes of proteinaceous material and con-
sequential macrophage accumulation in the air spaces as well as AECII hyperplasia can be
attributed to defective surfactant production and subsequent damage to the alveolar epithe-
lium. AECII hyperplasia occurs as a well-known reparative response to a damaging insult to
the alveolar epithelium with the eventual transformation of AECII into AECI cells in this pro-
cess [32,33]. The pathogenesis of the characteristic arrest of the acinar development and inter-
stitial thickening with mesenchymal cells has not been closely studied. In the stillborn affected
puppy, the acinar structure was in the saccular stage of development, which is normal for at
term puppies [20] and interstitial thickening was not apparent at this stage, whereas the afore-
mentioned abnormalities were clearly seen in the older affected puppies. This suggests that the
acinar and interstitial changes manifest and progress during breathing and that these changes
could be secondary and reflect a reparative mechanism to the injured alveolar septa and atelec-
tasis. Alternatively, they could be a consequence of a yet unknown process.
In the TEM analysis of the affected lungs, AECII hyperplasia was evident in the alveolar epi-
thelium. Moreover, the observed ultrastructural damage to the epithelium and underlying
basal lamina had preceded the intra-alveolar accumulation of proteinaceous oedema fluid.
This was seen as floccular material mixed with unilamellar vesicles of surfactant in the alveolar
space in contrast to the normal lamellar body-like to tubular myelin structures of surfactant in
the control lung [34]. The severe ultrastructural alterations of the intracellular organelles in the
affected AECII cells were typical for ischemic change that can occur secondary to alterations
in surfactant composition or function, whether the primary mechanism is genetic or ischemic
or due to reperfusion injury in e.g. lung transplantation [2,35]. In the affected but still intact
AECII cells, LBs were underdeveloped, in the developmental stage of CBs with occasional dis-
ruption of the limiting membrane, which clearly indicates an impairment in the formation of
this membrane and subsequent defect in LB formation. The arrest in maturation cannot be
attributed to ischemia, since in an experimental study on ischemia related ultrastructural
changes in canine AECII cells, the cytoplasmic surfactant organelles were well preserved [35].
A delayed post-mortem period before fixation can certainly cause similar changes as in ische-
mia, but this post-mortem artefact is unlikely as the sampling of both the affected and control
puppy had occurred at a similar post-mortem interval, and the ultrastructure of the control
lung was well preserved. Without the proper amount and composition of surfactant, the alveoli
collapse as the surface tension increases and a progressive vicious cycle develops as the areas of
atelectatic alveoli are no longer ventilated and perfused due to hypoxic vasoconstriction [35].
In the affected AT puppies, the observation of improperly matured LBs in the affected
AECII cells supports our hypothesis of a primary defect in the surfactant metabolism as the
underlying mechanism for the disease. As the human surfactant deficiencies caused by patho-
genic variants in ABCA3, SFTPB and SFTPC have distinct ultrastructural changes in the LBs,
TEM has been the golden standard for diagnosis prior to the genomic methods available
today. The ultrastructural feature of arrested LB maturation that is observed as structures com-
patible with CBs in the cytoplasm without normally formed, mature LBs in the affected pup-
pies is also the hallmark finding in human SP-B deficiencies [36,37]. In contrast, the typical
findings of human ABCA3 and SP-C deficiencies are different to what we observed in the
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affected puppies. As for ABCA3 deficiency, depending on the pathogenicity of ABCA3 vari-
ants, the LBs have a distinct ultrastructural morphology of "fried eggs” as the abnormal LBs
have tightly packed lamellae and an aggregation of electron dense material [7,36]. In human
SP-C deficiencies, the intracytoplasmic LBs appear to be enlarged and contain disorganized
lamellar structures [38], which is in contrast to SP-C deficient mice that have no observable
ultrastructural changes in the LBs [39].
LAMP3 was originally found to be transiently expressed in the MHC class II compartment
of dendritic cells [17]. Liao et al. [40] showed that LAMP3 regulates hepatic lipid metabolism,
which suggests that LAMP3 can be of relevance as a drug target in disorders of lipid metabo-
lism. In cancer biology, e.g. overexpression of LAMP3 is associated with potential metastatic
cervical cancer [41]. As LAMP3 is expressed in the limiting membrane of LBs in alveolar
AECII cells, it is an excellent candidate for surfactant dysfunction [19].
LAMP3 belongs to the lysosome-associated membrane protein family that share a con-
served LAMP domain [42]. LAMP3 is a highly glycosylated single transmembrane protein
with an intraorganellar N-terminal signal peptide, a LAMP domain with two conserved disul-
fide bonds, multiple O- and N-linked glycosylation sites and a transmembrane helix before a
short cytoplasmic C-terminal tail [42]. Wilke et al. [42] revealed the secondary crystal structure
of the human LAMP domain in LAMP3. This domain has a unique β prism fold that is stabi-
lized by two disulfide bonds at the cysteine residues. The prism structure is conserved across
LAMP domains and is formed by two β-pleated sheets that are bent by β-bulges and connected
by the second disulfide bond [42,43]. The LAMP3 p.(E387K) variant resides within the LAMP
domain adjacent to the fourth cysteine residue that is involved in the formation of the second
disulfide bond, which stabilizes the C-terminus of the protein in the center of the β-prism [42].
Multiple alignment of LAMP3 amino acid sequences across species indicates that p.E387 is
conserved (S6 Table). Although we lack functional evidence at this stage, it is possible that the
change from negatively charged glutamic acid into positively charged lysine next to the S-S
bond may distort the native conformation of the LAMP domain and thus disturb the interac-
tion with other limiting membrane proteins in the process of mature LB formation. As LB
maturation in the affected puppies had ceased at the CB stage, a failure in the formation of a
proper limiting membrane is plausible. Without a proper limiting membrane, the acidic
intraorganellar environment is disturbed, which consequently affects the posttranslational
proteolytic processing of the limiting membrane glycoprotein ABCA3 and surfactant proteins
SP-B and SP-C, as the necessary enzymes are not properly enclosed within the MVBs, CBs and
LBs [44–46]. Moreover, without the normal function of ABCA3 as a transmembrane lipid
transporter in the limiting membrane, further detrimental effect in surfactant biogenesis
ensues, as the transportation of lipids into the surfactant processing organelles ceases [47,48].
This aforementioned combined global dysfunction most likely explains the severity of the dis-
ease in the affected puppies.
We were unable to study the functional consequence of the LAMP3 variant at protein level
since neither snap frozen tissue samples nor bronchoalveolar lavage fluid were available from
the affected puppies. However, LAMP3 IHC on paraffin embedded lung tissue indicated simi-
lar expression of the protein in the affected and control lungs, suggesting a pathogenic confor-
mational defect in the mutated protein. In the affected one to four days old puppies, the intra-
alveolar proteinaceous material stained intensely positive with SP-B antibody, whereas it
stained only slightly with SP-C. This suggests a possible overproduction of SP-B and a reduc-
tion of SP-C in the affected puppies, since a similar relative change in the amount of these pro-
teins has been reported in a patient with a homozygous missense ABCA3 variant [49]. This
abnormality in SP-B and SP-C production in the affected puppies and child with ABCA3 vari-
ant might be caused by a comparable underlying mechanism.
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LAMP3 is a novel candidate gene for human surfactant deficiencies. A syndrome caused by
3q26.33-3q27.2 microdeletion haploinsufficiency overlapping LAMP3 has been recently pro-
posed in children [50,51]. In these cases, possible pathological changes in the lungs were not
confirmed by biopsy, thus making the pathogenicity of LAMP3+/- uncertain. However, the
children responded to therapy and clinical symptoms were mild compared to the affected pup-
pies, suggesting that the haploinsufficiency with 3q26.33-3q27.2 microdeletion syndrome
yields enough functional protein to maintain pulmonary function to avoid lethality. By
sequencing the known disease-causing variants or the whole candidate gene in surfactant dis-
orders, the underlying genetic defect is commonly found. However, Somaschini et al. [52]
have reported lethal respiratory distress in three newborn infants without pathogenic coding
or intron-exon boundary variants in ABCA3, SFTPB or SFTPC and they speculated of a yet
unknown underlying genetic mechanism. Our study suggests that in unresolved cases of inter-
stitial lung disease in neonatal babies, variants in LAMP3 should be closer investigated.
In conclusion, we have characterized a neonatal interstitial lung disease in a dog breed with
a missense variant in AECII cell LB limiting membrane protein LAMP3. This finding provides
a novel candidate gene and new insights to LB biology. Furthermore, a genetic test can be
developed for veterinary diagnostic and breeding purposes to eradicate this severe disease
from the AT breed.
Materials and methods
Ethics statement
The tissue samples were collected during necropsy and the blood sample collection was ethi-
cally approved by the Animal Ethics Committee of State Provincial Office of Southern Finland
(ESAVI/7482/04.10.07/2015). All dogs had been voluntarily sent for necropsy by the breeder
or owner.
Study animals and pedigrees
The study cohort comprised of 371 AT dogs and included altogether 44 puppies and 3 adult
dogs that had been sent for a pathological examination. Unaffected age-matched puppies from
other breeds were used as controls in this study. EDTA blood samples were collected from 324
unaffected AT dogs, including parents, siblings and close relatives of the affected puppies. The
pedigree of the affected puppies was visualized with the GenoPro software (version 2.5.4.1).
Pedigree information was obtained from the public database of the Finnish Kennel Club [53].
Postmortem examination
A necropsy was performed on all affected puppies. Samples for histology from all lung lobes
(multiple sections), major organs and macroscopically abnormal tissues were collected and
fixed in 10% buffered formalin, routinely processed and embedded in paraffin. Lung samples
were cut into 2 μm, other organs into 4 μm sections and all were stained with Hematoxylin
and Eosin (HE) and examined by light microscopy. Special stains Periodic Acid-Schiff (PAS)
for glycoprotein and Masson Trichrome (MTRI) for fibrosis were used on lung tissue (4 μm
sections). Lung tissue samples collected during necropsy from age-matched unaffected AT
puppies and puppies from other breeds were used as controls.
Transmission Electron Microscopy (TEM)
A 1.5-day-old affected puppy and an age-matched unaffected puppy from another breed had
been dead for two hours and kept at 4˚C prior to necropsy. Lung tissue samples were
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immediately immersed into 5% glutaraldehyde in 0,16 M s-collidin buffer, pH 7,4 during nec-
ropsy. The samples were stored in this media and sent to University of Turku, Laboratory of
Electron Microscopy. Next, the samples were washed in s-collidin buffer three times, 3 min
each. Post fixation was done with 2% OsO4 + 3% K-ferrocyanide (1:1) for 2 hr [54]. After post
fixation, the samples were washed three times in s-collidin buffer, 5 min each. The dehydration
process was done using ascending concentration of ethanol starting with 70% ethanol, 1 min
at +4˚C; 96% ethanol, 1 min at +4˚C; 100% ethanol, 30 min at +4˚C; and finally, 100% ethanol,
3 times, 30 min each at +20˚C. For embedding, the samples were first kept in propylene oxide
two times, 15 min each; next, in propylene oxide with epoxy resin and DMP (10:10:0,15) for 2
hours prior to epoxy resin with DMP (10:0,15) for 12 hours; and finally, epoxy resin with
DMP (10:0,15) in +60˚C for 36 hours. The sections were cut with an ultramicrotome to a
thickness of approximately 70 nm. The samples were manually stained first with 1% uranyl
acetate in pure water for 30 min, after which they were rinsed in pure water three times, 30 sec
each and the final staining was done with 0.3% lead citrate in pure water for 3 min, following
three rinses in pure water, 30 sec each. The micrographs were taken using JEM-1400 Plus
transmission electron microscope (JEOL, Japan) operated at 80 kV.
Genotyping and GWAS
Illumina´s CanineHD Beadchip containing 173,662 SNPs was used for the genotyping of 5
affected puppies and 24 unaffected relatives at Geneseek (Neogen Corporation). A case-control
association study (GWAS) was performed with PLINK version 1.07 software [55]. Parameters
for the quality control were marker and sample call rate of> 95%, minor allele frequency
(MAF) of> 1% and Hardy-Weinberg equilibrium of p > 0.0001. No individual dogs were
removed after genotype pruning and frequency test; in total, 93401 SNPs remained in the anal-
ysis. Multiple testing correction was implemented with the Bonferroni method, and genome-
wide significance level was subsequently set to 5.353 x 10−7. Population stratification was
assessed with genomic inflation factor (lambda) and from a QQ plot after analysis (S1 Fig).
The QQ plot indicated a slight stratification in the cohort, which is typical for association stud-
ies in highly inbred and structured populations.
Whole exome sequencing
Two affected puppies and one obligate carrier of the AT breed were whole exome sequenced
by using Roche NimbleGen SeqCap EZ target enrichment design 140702_CanFam3_exome-
plus_BB_EZ_HX1 kit with a total capture size of ~152 Mb [56]. The sequencing was per-
formed with Illumina NextSeq500 at the Biomedicum Functional Genomics Unit (FuGU,
University of Helsinki). The acquired reads were mapped with the Burrows-Wheeler Aligner
(BWA) 0.7.12-r1039 version [57] and the mapped reads were categorized and the duplicates
marked with Picard tools [58]. Genome Analysis Tool Kit (GATK) HaplotypeCaller version
3.5.0 [59] was used for indel realignment, base-quality score realignment and variant calling.
For the identification of candidate variants, we performed filtering under an autosomal
recessive model using Genotype Query Tools [60,61] and an in-house variant database. Before
filtering, approximately 240 000 variants were present in each sample, out of which approxi-
mately 139 000 were homozygous (S2 Table). First, we selected variants that were homozygous
in the two affected puppies and heterozygous in the obligate carrier. To further narrow down
the set of candidate variants with control genomes, we utilized publicly available data from 197
unaffected dogs from 67 breeds and 3 wolves (S3 Table). CanFam3.1 was used as the reference
genome. For LAMP3, we used nucleotide acid sequence XM_843796.4 and XP_848889.2
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protein sequence. The whole exome sequences of three dogs have been deposited to the NCBI
SRA database with the accession number PRJNA515838.
Whole genome sequencing
One affected and one unaffected AT dog were whole genome sequenced by Illumina high-
throughput sequencer with paired-end strategy at a read length of 300 bp (2 x 150bp). The
affected and unaffected dog had an average coverage of 25X and 33X, respectively. The read
processing was performed as described above. In addition, structural variants (SVs) including
deletions, insertions, duplications, and intra-chromosomal re-arrangements were identified
with DELLY [62]. The consensus sequence for LINEs of type L1-Y_Cf (young active repeats)
and for the SINEC1_CF and SINEC2_CF families were obtained from Repbase database [63].
The Mobile Element Locator Tool (MELT) [64] was then used to discover and genotype the
non-reference mobile element insertions (MEI), namely SINEs and LINEs, in the sequenced
dogs. The SVs and MEIs were filtered assuming autosomal recessive mode of inheritance,
where the variant was required to be homozygous in the affected dog and wild-type in 257
additional unaffected dogs.
Immunohistochemistry (IHC)
Formalin fixed, paraffin embedded lung samples were cut into 2 μm sections. The following
primary antibodies and dilutions were used: Anti-mouse DC-LAMP/CD208 rat monoclonal
antibody (1:100, DDX0191, Dendritics) that has previously been used on dog tissue [65]. Anti-
human SFTPB /Surfactant protein B rabbit polyclonal antibody (1:400, LS-B8081, LifeSpan
BioSciences LSBio) that corresponds with 86% similarity to residues 154–202 of the canine
surfactant protein B (XP_013975904.1), and SFTPC anti-human rabbit polyclonal antibody
(1:200, PA5-76631, Thermo Fisher) that is produced against the recombinant full-length
human protein that corresponds with 79% identity to dog surfactant protein C (XP_534578.4).
The sections were deparaffinized in UltraClear (J.T Baker) and rehydrated in graded ethanol
series. Heat induced antigen retrieval in citrate buffer (pH 6) for 20 minutes in microwave was
performed for DC-LAMP/CD208 and SFTPB whereas no retrieval method was used for
SFTPC. Fresh 1% of H2O2/MetOH for 10 minutes was used to block endogenous peroxidase
activity in all samples prior to 5 minutes in Ultra Vision Protein Block (UltraVision LP Detec-
tion System HRP Polymer & AEC Chromogen, Thermo Scientific). Sections stained with
DC-LAMP/CD208 and SFTPB antibodies were incubated overnight in +4˚C and SFTPC sec-
tions in room temperature (RT) for 1 hour. BrightVision (ImmunoLogic) post-antibody
blocking solution (for 15 minutes) was used for DC-LAMP/CD208 stained sections and Ultra-
Vision Primary Antibody Enhancer (20 minutes in RT) for the sections stained with the other
two antibodies. The SFTPC stained sections were incubated for 30 minutes in RT whereas
SFTPB sections were incubated for 45 minutes in +37˚C with the secondary antibody, UltraVi-
sion HRP polymer. BrightVision Poly-HRP-Goat anti Mouse/Rabbit IgG secondary antibody
(ImmunoLogic) was used for DC-LAMP/CD208 according to manufacturer’s instruction.
UltraVision AEC Single Solution chromogen (Thermo Fisher) was used for all sections to visu-
alize the reactions as well as counterstaining with Meyers hematoxylin prior to Aquatex
(Merck) mounting.
Sanger sequencing
The three identified variants in chr34 (Table 1.) were genotyped by standard PCR and Sanger
sequencing. Gene-specific primers were designed using Primer3 [66]. The PCR primers used
in genotyping were: LAMP3 forward 5’-ATGATTCGCGTCTTAGGTGGA-3’ and reverse 5’-
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TAAAAGTCAAGCCCGGTTGT-3’; ABCC5 forward 5’-GCCTTTTCTTGCTGAGTTCATG-
3’ and reverse 5’-TCAACCACCAATTGCTGAAGG-3’; KLHL6 forward 5’-TGAATGCCCA
CTGTGTTTCC-3’ and reverse 5’-AGAACACACTCCTCCGTCAG-3’. Biotools DNA Poly-
merase was used for the amplification and the PCR products were purified using Exonuclease
I (20U/μl, Thermo Fischer Scientific) and FastAP (1 U/ μl, Thermo Fischer Scientific). The
PCR products were sequenced with forward primer using ABI 3730 capillary sequencer
(Applied Biosystems, Life Technologies) at the Institute for Molecular Medicine Finland core
facility (FIMM, Technology Centre, University of Helsinki, Helsinki, Finland). Sequencher 5.1
(GeneCodes) was used to analyze the Sanger sequence data.
Large-scale variant screening
Additional screening for the LAMP3 variant was carried out in a diverse sample set of dogs
representing 297 breeds (S7 Table) submitted for routine commercial screening at Genoscoper
Laboratories Oy, Helsinki, during 2018–2019. Genotyping was carried out according to manu-
facturer-recommended standard protocols on a custom designed Illumina Infinum XT geno-
typing bead chip (Illumina, San Diego, CA, USA) commercially available as the MyDogDNA /
Optimal Selection panel test [67,68].
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